Alsop, D., & Vijayan, M. (2009). The zebrafish stress axis: molecular fallout from the teleost-specific genome duplication event. General and comparative endocrinology, 161(1), 62-66.
Ando, T., & Dunn, A. J. (1999). Mouse tumor necrosis factor-α increases brain tryptophan concentrations and norepinephrine metabolism while activating the HPA axis in mice. Neuroimmunomodulation, 6(5), 319-329.
Benarroch, E. E. (2013). Microglia: Multiple roles in surveillance, circuit shaping, and response to injury. Neurology, 81(12), 1079-1088.
Brebner, K., Hayley, S., Zacharko, R., Merali, Z., & Anisman, H. (2000). Synergistic effects of interleukin-1β, interleukin-6, and tumor necrosis factor-α: central monoamine, corticosterone, and behavioral variations. Neuropsychopharmacology, 22(6), 566-580.
Brodin, T., Fick, J., Jonsson, M., & Klaminder, J. (2013). Dilute concentrations of a psychiatric drug alter behavior of fish from natural populations. Science, 339(6121), 814-815.
Brynskikh, A., Warren, T., Zhu, J., & Kipnis, J. (2008). Adaptive immunity affects learning behavior in mice. Brain, behavior, and immunity, 22(6), 861-869.
Bustin, S. A., Benes, V., Garson, J., Hellemans, J., Huggett, J., Kubista, M., . . . Shipley, G. (2013). The need for transparency and good practices in the qPCR literature. Nature methods, 10(11), 1063-1067.
Calabrese, J. R., Skwerer, R. G., Barna, B., Gulledge, A. D., Valenzuela, R., Butkus, A., . . . Krupp, N. E. (1986). Depression, immunocompetence, and prostaglandins of the E series. Psychiatry research, 17(1), 41-47.
Calisto, V., Domingues, M. R. M., & Esteves, V. I. (2011). Photodegradation of psychiatric pharmaceuticals in aquatic environments–Kinetics and photodegradation products. Water research, 45(18), 6097-6106.
Carboni, L., McCarthy, D. J., Delafont, B., Filosi, M., Ivanchenko, E., Ratti, E., . . . Domenici, E. (2019). Biomarkers for response in major depression: comparing paroxetine and venlafaxine from two randomised placebo-controlled clinical studies. Translational psychiatry, 9(1), 182.
Cassano, P., Hidalgo, A., Burgos, V., Adris, S., & Argibay, P. (2006). Hippocampal upregulation of the cyclooxygenase-2 gene following neonatal clomipramine treatment (a model of depression). The Pharmacogenomics Journal, 6(6), 381-387.
Chen, K., Wu, M., Chen, C., Xu, H., Wu, X., & Qiu, X. (2021). Impacts of chronic exposure to sublethal diazepam on behavioral traits of female and male zebrafish (Danio rerio). Ecotoxicology and Environmental Safety, 208, 111747.
Clark, D., Pazdernik, N., & McGehee, M. (2019). Cells and organisms. Molecular Biology, 3rd ed.; Clark, DP, Pazdernik, NJ, McGehee, MR, Eds, 2-37.
Dantzer, R. (2006). Cytokine, sickness behavior, and depression. Neurologic clinics, 24(3), 441-460.
Dantzer, R., & Kelley, K. W. (2007). Twenty years of research on cytokine-induced sickness behavior. Brain, behavior, and immunity, 21(2), 153-160.
Depression, W. (2017). Other common mental disorders: global health estimates. Geneva: World Health Organization, 24(1).
Djavadian, R. (2004). Serotonin and neurogenesis in the hippocampal dentate gyrus of adult mammals. Acta neurobiologiae experimentalis, 64(2), 189-200.
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010). A meta-analysis of cytokines in major depression. Biological psychiatry, 67(5), 446-457.
Egan, R. J., Bergner, C. L., Hart, P. C., Cachat, J. M., Canavello, P. R., Elegante, M. F., . . . Tien, D. H. (2009). Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish. Behavioural brain research, 205(1), 38-44.
Eghbali, M., Curmi, J., Birnir, B., & Gage, P. (1997). Hippocampal GABAAchannel conductance increased by diazepam. Nature, 388(6637), 71-75.
Eyre, H. A., Air, T., Proctor, S., Rositano, S., & Baune, B. T. (2015). A critical review of the efficacy of non-steroidal anti-inflammatory drugs in depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 57, 11-16.
Faikoh, E. N., Hong, Y.-H., & Hu, S.-Y. (2014). Liposome-encapsulated cinnamaldehyde enhances zebrafish (Danio rerio) immunity and survival when challenged with Vibrio vulnificus and Streptococcus agalactiae. Fish & Shellfish Immunology, 38(1), 15-24.
Faria, M., Bellot, M., Soto, O., Prats, E., Montemurro, N., Manjarrés, D., . . . Raldúa, D. (2022). Developmental exposure to sertraline impaired zebrafish behavioral and neurochemical profiles. Frontiers in physiology, 13, 1040598.
Fornaro, M., Rocchi, G., Escelsior, A., Contini, P., & Martino, M. (2013). Might different cytokine trends in depressed patients receiving duloxetine indicate differential biological backgrounds. Journal of affective disorders, 145(3), 300-307.
Goessling, W., & Sadler, K. C. (2015). Zebrafish: an important tool for liver disease research. Gastroenterology, 149(6), 1361-1377.
Gunnarsson, L., Jauhiainen, A., Kristiansson, E., Nerman, O., & Larsson, D. J. (2008). Evolutionary conservation of human drug targets in organisms used for environmental risk assessments. Environmental science & technology, 42(15), 5807-5813.
Hannestad, J., DellaGioia, N., & Bloch, M. (2011). The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology, 36(12), 2452-2459.
Hayley, S., Poulter, M., Merali, Z., & Anisman, H. (2005). The pathogenesis of clinical depression: stressor-and cytokine-induced alterations of neuroplasticity. Neuroscience, 135(3), 659-678.
Herculano, A. M., & Maximino, C. (2014). Serotonergic modulation of zebrafish behavior: Towards a paradox. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 55, 50-66.
Hinson, R. M., Williams, J. A., & Shacter, E. (1996). Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2. Proceedings of the National Academy of Sciences, 93(10), 4885-4890.
Horzmann, K. A., & Freeman, J. L. (2018). Making waves: New developments in toxicology with the zebrafish. Toxicological Sciences, 163(1), 5-12.
Keller, J., Gomez, R., Williams, G., Lembke, A., Lazzeroni, L., Murphy, G. M., & Schatzberg, A. F. (2017). HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition. Molecular psychiatry, 22(4), 527-536.
Lam, R. W. (2012). Onset, time course and trajectories of improvement with antidepressants. European Neuropsychopharmacology, 22, S492-S498.
Leite, C. E., de Oliveira Maboni, L., Cruz, F. F., Rosemberg, D. B., Zimmermann, F. F., Pereira, T. C. B., . . . Morrone, F. B. (2013). Involvement of purinergic system in inflammation and toxicity induced by copper in zebrafish larvae. Toxicology and applied pharmacology, 272(3), 681-689.
Leonard, B., & Maes, M. (2012). Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neuroscience & Biobehavioral Reviews, 36(2), 764-785.
Levin, E. D., Bencan, Z., & Cerutti, D. T. (2007). Anxiolytic effects of nicotine in zebrafish. Physiology & behavior, 90(1), 54-58.
MacQueen, G., Born, L., & Steiner, M. (2001). The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders. CNS Drug Reviews, 7(1), 1-24.
Maes, M. (1999). Major depression and activation of the inflammatory response system. Cytokines, stress, and depression, 25-46.
Maes, M., Berk, M., Goehler, L., Song, C., Anderson, G., Gałecki, P., & Leonard, B. (2012). Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC medicine, 10, 1-19.
Maes, M., Kubera, M., Obuchowiczwa, E., Goehler, L., & Brzeszcz, J. (2011). Depression’s multiple comorbidities explained by (neuro) inflammatory and oxidative & nitrosative stress pathways. Neuroendocrinol Lett, 32(1), 7-24.
Maes, M., Meltzer, H. Y., Cosyns, P., Suy, E., & Schotte, C. (1993). An evaluation of basal hypothalamic-pituitary-thyroid axis function in depression: results of a large-scaled and controlled study. Psychoneuroendocrinology, 18(8), 607-620.
Maes, M., Vandoolaeghe, E., Ranjan, R., Bosmans, E., Bergmans, R., & Desnyder, R. (1995). Increased serum interleukin-1-receptor-antagonist concentrations in major depression. Journal of affective disorders, 36(1-2), 29-36.
Manuel, R., Gorissen, M., Zethof, J., Ebbesson, L. O., van de Vis, H., Flik, G., & van den Bos, R. (2014). Unpredictable chronic stress decreases inhibitory avoidance learning in Tuebingen long-fin zebrafish: stronger effects in the resting phase than in the active phase. Journal of Experimental Biology, 217(21), 3919-3928.
Marcon, M., Herrmann, A. P., Mocelin, R., Rambo, C. L., Koakoski, G., Abreu, M. S., . . . Zanatta, L. (2016). Prevention of unpredictable chronic stress-related phenomena in zebrafish exposed to bromazepam, fluoxetine and nortriptyline. Psychopharmacology, 233, 3815-3824.
Martinowich, K., & Lu, B. (2008). Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology, 33(1), 73-83.
Mesquita, A. R., Correia-Neves, M., Roque, S., Castro, A. G., Vieira, P., Pedrosa, J., . . . Sousa, N. (2008). IL-10 modulates depressive-like behavior. Journal of psychiatric research, 43(2), 89-97.
Mihailova, S., Ivanova-Genova, E., Lukanov, T., Stoyanova, V., Milanova, V., & Naumova, E. (2016). A study of TNF-α, TGF-β, IL-10, IL-6, and IFN-γ gene polymorphisms in patients with depression. Journal of neuroimmunology, 293, 123-128.
Minghetti, L. (2004). Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. Journal of Neuropathology & Experimental Neurology, 63(9), 901-910.
Mocelin, R., Marcon, M., D’ambros, S., Mattos, J., Sachett, A., Siebel, A. M., . . . Piato, A. (2019). N-acetylcysteine reverses anxiety and oxidative damage induced by unpredictable chronic stress in zebrafish. Molecular Neurobiology, 56, 1188-1195.
Müller, N., Myint, A.-M., & Schwarz, M. J. (2009). The impact of neuroimmune dysregulation on neuroprotection and neurotoxicity in psychiatric disorders-relation to drug treatment. Dialogues in clinical neuroscience, 11(3), 319-332.
Müller, N., Myint, A.-M., & Schwarz, M. J. (2011). Inflammatory biomarkers and depression. Neurotoxicity research, 19, 308-318.
Muscat, R., Papp, M., & Willner, P. (1992). Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline. Psychopharmacology, 109, 433-438.
Nobis, A., Zalewski, D., & Waszkiewicz, N. (2020). Peripheral markers of depression. Journal of clinical medicine, 9(12), 3793.
Overstreet, D. H., & Wegener, G. (2013). The flinders sensitive line rat model of depression—25 years and still producing. Pharmacological reviews, 65(1), 143-155.
Pavlidis, M., Theodoridi, A., & Tsalafouta, A. (2015). Neuroendocrine regulation of the stress response in adult zebrafish, Danio rerio. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 60, 121-131.
Piato, Â. L., Capiotti, K. M., Tamborski, A. R., Oses, J. P., Barcellos, L. J., Bogo, M. R., . . . Bonan, C. D. (2011). Unpredictable chronic stress model in zebrafish (Danio rerio): behavioral and physiological responses. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 35(2), 561-567.
Pomara, N., Willoughby, L. M., Sidtis, J. J., Cooper, T. B., & Greenblatt, D. J. (2005). Cortisol response to diazepam: its relationship to age, dose, duration of treatment, and presence of generalized anxiety disorder. Psychopharmacology, 178, 1-8.
Porsolt, R. D., Le Pichon, M., & Jalfre, M. (1977). Depression: a new animal model sensitive to antidepressant treatments. Nature, 266(5604), 730-732.
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., . . . Lebowitz, B. D. (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR* D report. American Journal of Psychiatry, 163(11), 1905-1917.
SAPOLSKY, R. M., KREY, L. C., & McEWEN, B. S. (1984). Stress down-regulates corticosterone receptors in a site-specific manner in the brain. Endocrinology, 114(1), 287-292.
Schiepers, O. J., Wichers, M. C., & Maes, M. (2005). Cytokines and major depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 29(2), 201-217.
Segner, H. (2009). Zebrafish (Danio rerio) as a model organism for investigating endocrine disruption. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, 149(2), 187–195.
Tang, R., Dodd, A., Lai, D., McNabb, W. C., & Love, D. R. (2007). Validation of zebrafish (Danio rerio) reference genes for quantitative real-time RT-PCR normalization. Acta biochimica et biophysica Sinica, 39(5), 384-390.
Tovote, P., Fadok, J. P., & Lüthi, A. (2015). Neuronal circuits for fear and anxiety. Nature Reviews Neuroscience, 16(6), 317-331.
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T., Mazur, M., & Telser, J. (2007). Free radicals and antioxidants in normal physiological functions and human disease. The international journal of biochemistry & cell biology, 39(1), 44-84.
Varela, M., Dios, S., Novoa, B., & Figueras, A. (2012). Characterisation, expression and ontogeny of interleukin-6 and its receptors in zebrafish (Danio rerio). Developmental & Comparative Immunology, 37(1), 97-106.
Wang, H., Li, P., Zhang, Y., Zhang, C., Li, K., & Song, C. (2020). Cytokine changes in different types of depression: specific or general? Neurology, Psychiatry and Brain Research, 36, 39-51.
Wang, Q., Timberlake II, M. A., Prall, K., & Dwivedi, Y. (2017). The recent progress in animal models of depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 77, 99-109.
Więdłocha, M., Marcinowicz, P., Krupa, R., Janoska-Jaździk, M., Janus, M., Dębowska, W., . . . Szulc, A. (2018). Effect of antidepressant treatment on peripheral inflammation markers–A meta-analysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 80, 217-226.
Willner, P., Muscat, R., & Papp, M. (1992). Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neuroscience & Biobehavioral Reviews, 16(4), 525-534.
Zhang, S., Liu, X., Sun, M., Zhang, Q., Li, T., Li, X., . . . Feng, X. (2018). Reversal of reserpine-induced depression and cognitive disorder in zebrafish by sertraline and Traditional Chinese Medicine (TCM). Behavioral and Brain Functions, 14, 1-14.
Zhao, Y., Wang, Z., Dai, J., Chen, L., Huang, Y., & Zhan, Z. (2012). Beneficial effects of benzodiazepine diazepam on chronic stress-induced impairment of hippocampal structural plasticity and depression-like behavior in mice. Behavioural brain research, 228(2), 339-350.
Zhu, C., Zhang, T., Li, Q., Chen, X., & Wang, K. (2023). Depression and anxiety during the COVID-19 pandemic: epidemiology, mechanism, and treatment. Neuroscience Bulletin, 39(4), 675-684.
Zimmermann, F., Altenhofen, S., Kist, L., Leite, C., Bogo, M., Cognato, G., & Bonan, C. D. (2016). Unpredictable chronic stress alters adenosine metabolism in zebrafish brain. Molecular Neurobiology, 53, 2518-2528.
